TICLOPIDINE HYDROCHLORIDE Drug Patent Profile
✉ Email this page to a colleague
When do Ticlopidine Hydrochloride patents expire, and what generic alternatives are available?
Ticlopidine Hydrochloride is a drug marketed by Actavis Elizabeth, Apotex, Chartwell Rx, Mylan, Sun Pharm Inds Inc, Teva, and Watson Labs. and is included in nine NDAs.
The generic ingredient in TICLOPIDINE HYDROCHLORIDE is ticlopidine hydrochloride. There are nine drug master file entries for this compound. Additional details are available on the ticlopidine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Ticlopidine Hydrochloride
A generic version of TICLOPIDINE HYDROCHLORIDE was approved as ticlopidine hydrochloride by APOTEX on July 1st, 1999.
Summary for TICLOPIDINE HYDROCHLORIDE
US Patents: | 0 |
Applicants: | 7 |
NDAs: | 9 |
Raw Ingredient (Bulk) Api Vendors: | 113 |
Clinical Trials: | 39 |
Patent Applications: | 4,328 |
Formulation / Manufacturing: | see details |
DailyMed Link: | TICLOPIDINE HYDROCHLORIDE at DailyMed |
Recent Clinical Trials for TICLOPIDINE HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Kafrelsheikh University | Phase 3 |
Ain Shams University | Phase 3 |
Janssen Research & Development, LLC | Phase 1 |
Medical Subject Heading (MeSH) Categories for TICLOPIDINE HYDROCHLORIDE
Anatomical Therapeutic Chemical (ATC) Classes for TICLOPIDINE HYDROCHLORIDE
US Patents and Regulatory Information for TICLOPIDINE HYDROCHLORIDE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Actavis Elizabeth | TICLOPIDINE HYDROCHLORIDE | ticlopidine hydrochloride | TABLET;ORAL | 075253-001 | Aug 20, 1999 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Sun Pharm Inds Inc | TICLOPIDINE HYDROCHLORIDE | ticlopidine hydrochloride | TABLET;ORAL | 075526-001 | Sep 26, 2002 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Chartwell Rx | TICLOPIDINE HYDROCHLORIDE | ticlopidine hydrochloride | TABLET;ORAL | 075326-001 | Aug 20, 1999 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |